Closing the Gap: Evaluating the Safety and Effectiveness of Diabetic Ketoacidosis Nomograms
Annals of Pharmacotherapy · 2025
DOI: 10.1177/10600280251388640 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Amina Ammar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Eugene Applebaum College of Pharmacy & Health Sciences, Wayne State University, Detroit, MI, USA. Hauptthemen laut MEDLINE: Diabetic Ketoacidosis, Nomograms, Insulin, Hypoglycemic Agents. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
Diabetic ketoacidosis (DKA) is a severe complication of diabetes mellitus requiring insulin. However, there is no consensus on insulin infusion titration strategies, resulting in varied nomograms and potentially suboptimal management. Limited comparative data on insulin nomograms underscore the need for a standardized, evidence-based approach.
Objective
The purpose of this study is to evaluate the safety and effectiveness of 3 DKA nomograms.
Methods
This multicenter, retrospective observational study included adult patients with confirmed DKA treated with IV insulin for ≥3 hours. Each site used a different variable-rate nomogram: variable rate weight-adjusted IV insulin infusion with no bolus (VR-W-NB), variable-rate IV insulin infusion with bolus (VR-B) or variable-rate IV insulin infusion with no bolus (VR-NB). The primary endpoint was the incidence of hypoglycemia (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eugene Applebaum College of Pharmacy & Health Sciences, Wayne State University, Detroit, MI, USA.
- Department of Pharmacy, Henry Ford St. John Hospital, Detroit, MI, USA.
- Department of Pharmacy, Ascension Seton Medical Center, Austin, TX, USA.
- Department of Pharmacy, Prime Healthcare, Chicago, IL, USA.
- Department of Pharmacy, Ascension Healthcare, Bolingbrook, IL, USA.
- Henry Ford Warren Hospital, Warren, MI, USA.
ORCID-Profile: Amina Ammar, Brandon Tatar, Kristin M Janzen, Janci Addison, Christopher Guiliano
Zitieren
APA
Ammar, A., Fardoun, H., Hart, E., Cagadas, E., Tatar, B., Ng, T. H., Janzen, K. M., Addison, J., & Guiliano, C. (2025). Closing the Gap: Evaluating the Safety and Effectiveness of Diabetic Ketoacidosis Nomograms. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251388640
Vancouver
Ammar A, Fardoun H, Hart E, Cagadas E, Tatar B, Ng TH, et al. Closing the Gap: Evaluating the Safety and Effectiveness of Diabetic Ketoacidosis Nomograms. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280251388640
BibTeX
@article{Ammar2025,
author = {Ammar, Amina and Fardoun, Hassan and Hart, Elizabeth and Cagadas, Erin and Tatar, Brandon and Ng, Tsz Hin and Janzen, Kristin M and Addison, Janci and Guiliano, Christopher},
title = {Closing the Gap: Evaluating the Safety and Effectiveness of Diabetic Ketoacidosis Nomograms},
journal = {Annals of Pharmacotherapy},
year = {2025},
doi = {10.1177/10600280251388640}
}
EUVIMED